DSM secures victory in patent infringement litigation against Anhui Tiger
Tiger can no longer make an important biotin intermediate using a DSM patented process.
Tiger can no longer make an important biotin intermediate using a DSM patented process.
Promising drug pipeline, focus on gene therapy and innovative digital health solutions will remain the key pillars of Bayer’s pharmaceutical business
Subscribe To Our Newsletter & Stay Updated